Literature DB >> 22420949

Hypereosinophilia driven by GM-CSF in large-cell carcinoma of the lung.

Verena Lammel1, Christina Stoeckle, Barbara Padberg, Roland Zweifel, Dirk L Kienle, Walter H Reinhart, Hans-Uwe Simon.   

Abstract

In contrast to leukocytosis, paraneoplastic hypereosinophilia is uncommon in lung cancer. We present a patient with large-cell carcinoma of the lung, in which cancer cells generate large amounts of GM-CSF leading to a leukemoid reaction with prominent hypereosinophilia and potentially involved in autocrine tumor stimulation.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22420949     DOI: 10.1016/j.lungcan.2012.02.014

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  14 in total

1.  RhoH is a negative regulator of eosinophilopoiesis.

Authors:  Christina Stoeckle; Barbara Geering; Shida Yousefi; Saša Rožman; Nicola Andina; Charaf Benarafa; Hans-Uwe Simon
Journal:  Cell Death Differ       Date:  2016-10-14       Impact factor: 15.828

2.  Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway.

Authors:  Ting-Ting Wang; Yong-Liang Zhao; Liu-Sheng Peng; Na Chen; Weisan Chen; Yi-Pin Lv; Fang-Yuan Mao; Jin-Yu Zhang; Ping Cheng; Yong-Sheng Teng; Xiao-Long Fu; Pei-Wu Yu; Gang Guo; Ping Luo; Yuan Zhuang; Quan-Ming Zou
Journal:  Gut       Date:  2017-03-08       Impact factor: 23.059

3.  Hypereosinophilia in Solid Tumors-Case Report and Clinical Review.

Authors:  Ewa Zalewska; Łukasz Obołończyk; Krzysztof Sworczak
Journal:  Front Oncol       Date:  2021-03-24       Impact factor: 6.244

Review 4.  The Cellular Functions of Eosinophils: Collegium Internationale Allergologicum (CIA) Update 2020.

Authors:  Hans-Uwe Simon; Shida Yousefi; Nina Germic; Isabelle C Arnold; Angela Haczku; Alexander V Karaulov; Dagmar Simon; Helene F Rosenberg
Journal:  Int Arch Allergy Immunol       Date:  2019-11-29       Impact factor: 2.749

Review 5.  A role for G-CSF and GM-CSF in nonmyeloid cancers.

Authors:  Alexander M Aliper; Victoria P Frieden-Korovkina; Anton Buzdin; Sergey A Roumiantsev; Alex Zhavoronkov
Journal:  Cancer Med       Date:  2014-04-02       Impact factor: 4.452

6.  Chromophobe renal cell carcinoma associated with eosinophilia: A report of three cases.

Authors:  Yong-Bao Wei; Bin Yan; Zhuo Yin; Jin-Rui Yang
Journal:  Exp Ther Med       Date:  2014-05-20       Impact factor: 2.447

7.  CSF2 Overexpression Is Associated with STAT5 Phosphorylation and Poor Prognosis in Patients with Urothelial Carcinoma.

Authors:  Yi-Ying Lee; Wen-Jeng Wu; Chun-Nung Huang; Ching-Chia Li; Wei-Ming Li; Bi-Wen Yeh; Peir-In Liang; Ting-Feng Wu; Chien-Feng Li
Journal:  J Cancer       Date:  2016-03-26       Impact factor: 4.207

Review 8.  Stimulatory versus suppressive effects of GM-CSF on tumor progression in multiple cancer types.

Authors:  In-Sun Hong
Journal:  Exp Mol Med       Date:  2016-07-01       Impact factor: 8.718

9.  Myeloid-derived suppressor cells promote epithelial ovarian cancer cell stemness by inducing the CSF2/p-STAT3 signalling pathway.

Authors:  Xiaofeng Li; Jiapo Wang; Weimin Wu; Hao Gao; Na Liu; Guangxi Zhan; Li Li; Lingfei Han; Xiaoqing Guo
Journal:  FEBS J       Date:  2020-04-17       Impact factor: 5.542

10.  Genomic analysis of the prognostic value of colony-stimulating factors (CSFs) and colony-stimulating factor receptors (CSFRs) across 24 solid cancer types.

Authors:  Xinyi Huang; Pingping Hu; Jiandong Zhang
Journal:  Ann Transl Med       Date:  2020-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.